20-F 1 d290954d20f.htm FORM 20-F Form 20-F
Table of Contents
falseFYBoqii Holding Ltd0001815021true 0001815021 2020-04-01 2021-03-31 0001815021 2021-04-01 2022-03-31 0001815021 2022-04-01 2023-03-31 0001815021 2022-03-31 0001815021 2023-03-31 0001815021 2021-03-31 0001815021 2021-04-01 0001815021 2022-04-01 0001815021 2020-03-31 2020-03-31 0001815021 2018-07-25 2018-07-25 0001815021 2020-10-01 2020-10-31 0001815021 2020-10-31 0001815021 2022-01-01 2022-12-31 0001815021 2022-08-01 2022-08-31 0001815021 2021-01-01 2021-12-31 0001815021 2023-01-01 2023-12-31 0001815021 2022-05-31 0001815021 2020-03-31 0001815021 us-gaap:CommonClassAMember 2022-03-31 0001815021 us-gaap:CommonClassBMember 2022-03-31 0001815021 us-gaap:VariableInterestEntityPrimaryBeneficiaryMember us-gaap:NonrecourseMember 2022-03-31 0001815021 bq:ShanghaiGuangchengInformationMember 2022-03-31 0001815021 bq:WuhanChunzhijinMember 2022-03-31 0001815021 bq:MerchantTycoonLimitedMember 2022-03-31 0001815021 bq:YingzhilisaTangMember 2022-03-31 0001815021 bq:LijunZhouMember 2022-03-31 0001815021 bq:YanJiangMember 2022-03-31 0001815021 bq:NanjingAnimalPharmaceuticalMember 2022-03-31 0001815021 bq:FeiWangMember 2022-03-31 0001815021 bq:ProductSalesMember 2022-03-31 0001815021 bq:OnlineMarketingAndInformationServicesAndOtherRevenueMember 2022-03-31 0001815021 bq:SuperbOriginInternationalLimitedMember 2022-03-31 0001815021 bq:WeishiNetworkMember 2022-03-31 0001815021 bq:SoftwareMember 2022-03-31 0001815021 us-gaap:LeaseholdImprovementsMember 2022-03-31 0001815021 us-gaap:VehiclesMember 2022-03-31 0001815021 us-gaap:FurnitureAndFixturesMember 2022-03-31 0001815021 bq:WarehouseEquipmentMember 2022-03-31 0001815021 us-gaap:DistributionRightsMember 2022-03-31 0001815021 us-gaap:LicenseMember 2022-03-31 0001815021 us-gaap:TrademarksMember 2022-03-31 0001815021 currency:CNY us-gaap:CashMember 2022-03-31 0001815021 currency:CNY us-gaap:CashEquivalentsMember 2022-03-31 0001815021 currency:HKD us-gaap:CashMember 2022-03-31 0001815021 us-gaap:CashEquivalentsMember currency:HKD 2022-03-31 0001815021 us-gaap:CashMember currency:USD 2022-03-31 0001815021 us-gaap:CashEquivalentsMember currency:USD 2022-03-31 0001815021 us-gaap:CashMember currency:EUR 2022-03-31 0001815021 currency:EUR us-gaap:CashEquivalentsMember 2022-03-31 0001815021 us-gaap:CashMember currency:NZD 2022-03-31 0001815021 us-gaap:CashEquivalentsMember currency:NZD 2022-03-31 0001815021 us-gaap:CashEquivalentsMember 2022-03-31 0001815021 us-gaap:FairValueMeasurementsRecurringMember 2022-03-31 0001815021 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member 2022-03-31 0001815021 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel3Member 2022-03-31 0001815021 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel1Member 2022-03-31 0001815021 bq:WeightedAverageCostOfCapitalMember us-gaap:AvailableforsaleSecuritiesMember srt:MinimumMember 2022-03-31 0001815021 bq:WeightedAverageCostOfCapitalMember us-gaap:AvailableforsaleSecuritiesMember srt:MedianMember 2022-03-31 0001815021 srt:MaximumMember us-gaap:AvailableforsaleSecuritiesMember bq:WeightedAverageCostOfCapitalMember 2022-03-31 0001815021 us-gaap:MeasurementInputDiscountForLackOfMarketabilityMember us-gaap:AvailableforsaleSecuritiesMember srt:MinimumMember 2022-03-31 0001815021 us-gaap:MeasurementInputDiscountForLackOfMarketabilityMember us-gaap:AvailableforsaleSecuritiesMember srt:MedianMember 2022-03-31 0001815021 us-gaap:MeasurementInputDiscountForLackOfMarketabilityMember us-gaap:AvailableforsaleSecuritiesMember srt:MaximumMember 2022-03-31 0001815021 us-gaap:MeasurementInputRiskFreeInterestRateMember us-gaap:AvailableforsaleSecuritiesMember srt:MinimumMember 2022-03-31 0001815021 us-gaap:MeasurementInputRiskFreeInterestRateMember us-gaap:AvailableforsaleSecuritiesMember bq:MinimumOneMember 2022-03-31 0001815021 bq:MinimumTwoMember us-gaap:AvailableforsaleSecuritiesMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2022-03-31 0001815021 us-gaap:MeasurementInputRiskFreeInterestRateMember us-gaap:AvailableforsaleSecuritiesMember srt:MaximumMember 2022-03-31 0001815021 us-gaap:MeasurementInputPriceVolatilityMember us-gaap:AvailableforsaleSecuritiesMember srt:MinimumMember 2022-03-31 0001815021 us-gaap:MeasurementInputPriceVolatilityMember us-gaap:AvailableforsaleSecuritiesMember bq:MinimumOneMember 2022-03-31 0001815021 us-gaap:MeasurementInputPriceVolatilityMember us-gaap:AvailableforsaleSecuritiesMember bq:MinimumTwoMember 2022-03-31 0001815021 us-gaap:MeasurementInputPriceVolatilityMember us-gaap:AvailableforsaleSecuritiesMember srt:MaximumMember 2022-03-31 0001815021 us-gaap:AvailableforsaleSecuritiesMember bq:ProbabilityLiquidationScenarioMember 2022-03-31 0001815021 bq:ProbabilityRedemptionScenarioMember us-gaap:AvailableforsaleSecuritiesMember 2022-03-31 0001815021 bq:ProbabilityIpoScenarioMember us-gaap:AvailableforsaleSecuritiesMember 2022-03-31 0001815021 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember srt:MinimumMember 2022-03-31 0001815021 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember srt:MaximumMember 2022-03-31 0001815021 bq:AvailableForSaleDebtInvestmentsMember bq:QingdaoShuanganMember 2022-03-31 0001815021 bq:QingdaoShuanganBiotechnologyCoLtdMember 2022-03-31 0001815021 bq:BeijingPetdogTechnologyDevelopmentCoLtdMember 2022-03-31 0001815021 bq:NanjingAnimalPharmaceuticalMember 2022-03-31 0001815021 currency:CNY 2022-03-31 0001815021 us-gaap:ShortTermInvestmentsMember 2022-03-31 0001815021 us-gaap:ShortTermInvestmentsMember bq:ShortTermBankLoanMember 2022-03-31 0001815021 bq:ShortTermBankLoanMember 2022-03-31 0001815021 bq:LongTermLoanFromCmbMember 2022-03-31 0001815021 bq:LoanFromChongLiMember 2022-03-31 0001815021 bq:LoanForYokenSeriesAOneWarrantMember 2022-03-31 0001815021 bq:ConversionFeatureOfYokenSeriesAOneWarrantMember 2022-03-31 0001815021 bq:LoanForYokenSeriesAOneWarrantMember bq:YokenSeriesAOneWarrantMember 2022-03-31 0001815021 bq:YokenSeriesAOneWarrantMember 2022-03-31 0001815021 bq:ChongLiMember 2022-03-31 0001815021 bq:LongTermLoanFromCmbMember bq:CMBMember 2022-03-31 0001815021 us-gaap:EmployeeStockOptionMember srt:MaximumMember 2022-03-31 0001815021 us-gaap:EmployeeStockOptionMember srt:MinimumMember 2022-03-31 0001815021 us-gaap:CurrencySwapMember bq:NewForeignExchangeSwapContractThreeMember bq:NewForeignExchangeSwapContractMember 2022-03-31 0001815021 bq:NewForeignExchangeSwapContractMember bq:NewForeignExchangeSwapContractTwoMember us-gaap:CurrencySwapMember 2022-03-31 0001815021 bq:NewForeignExchangeSwapContractMember us-gaap:CurrencySwapMember bq:NewForeignExchangeSwapContractOneMember 2022-03-31 0001815021 bq:NewForeignExchangeSwapContractMember us-gaap:CurrencySwapMember 2022-03-31 0001815021 us-gaap:CommonClassAMember 2023-03-31 0001815021 us-gaap:CommonClassBMember 2023-03-31 0001815021 us-gaap:NonrecourseMember us-gaap:VariableInterestEntityPrimaryBeneficiaryMember 2023-03-31 0001815021 bq:ShanghaiGuangchengInformationMember 2023-03-31 0001815021 bq:WuhanChunzhijinMember 2023-03-31 0001815021 bq:MerchantTycoonLimitedMember 2023-03-31 0001815021 bq:YingzhilisaTangMember 2023-03-31 0001815021 bq:LijunZhouMember 2023-03-31 0001815021 bq:YanJiangMember 2023-03-31 0001815021 bq:NanjingAnimalPharmaceuticalMember 2023-03-31 0001815021 bq:FeiWangMember 2023-03-31 0001815021 bq:ProductSalesMember 2023-03-31 0001815021 bq:OnlineMarketingAndInformationServicesAndOtherRevenueMember 2023-03-31 0001815021 bq:SuperbOriginInternationalLimitedMember 2023-03-31 0001815021 bq:WeishiNetworkMember 2023-03-31 0001815021 bq:SoftwareMember 2023-03-31 0001815021 us-gaap:LeaseholdImprovementsMember 2023-03-31 0001815021 us-gaap:VehiclesMember 2023-03-31 0001815021 us-gaap:FurnitureAndFixturesMember 2023-03-31 0001815021 bq:WarehouseEquipmentMember 2023-03-31 0001815021 us-gaap:DistributionRightsMember 2023-03-31 0001815021 us-gaap:LicenseMember 2023-03-31 0001815021 us-gaap:TrademarksMember 2023-03-31 0001815021 us-gaap:CashMember currency:CNY 2023-03-31 0001815021 currency:CNY us-gaap:CashEquivalentsMember 2023-03-31 0001815021 us-gaap:CashMember currency:HKD 2023-03-31 0001815021 us-gaap:CashEquivalentsMember currency:HKD 2023-03-31 0001815021 currency:USD us-gaap:CashMember 2023-03-31 0001815021 currency:USD us-gaap:CashEquivalentsMember 2023-03-31 0001815021 us-gaap:CashMember currency:EUR 2023-03-31 0001815021 us-gaap:CashEquivalentsMember currency:EUR 2023-03-31 0001815021 us-gaap:CashMember currency:NZD 2023-03-31 0001815021 us-gaap:CashEquivalentsMember currency:NZD 2023-03-31 0001815021 us-gaap:CashEquivalentsMember 2023-03-31 0001815021 us-gaap:FairValueMeasurementsRecurringMember 2023-03-31 0001815021 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member 2023-03-31 0001815021 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2023-03-31 0001815021 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2023-03-31 0001815021 bq:BoqiiCorporationLimitedMember 2023-03-31 0001815021 bq:BoqiiInternationalLimitedMember 2023-03-31 0001815021 bq:XingmuInternationalLimitedMember 2023-03-31 0001815021 bq:XingmuHkLimitedMember 2023-03-31 0001815021 bq:NanjingXinmuInformationTechnologyCoLtdMember 2023-03-31 0001815021 bq:XinchengshanghaiInformationTechnologyCoLtdMember 2023-03-31 0001815021 bq:ShanghaiYiqinPetsProductsCoLtdMember 2023-03-31 0001815021 bq:ShanghaiEverySupplyChainCoLtdMember 2023-03-31 0001815021 bq:ImpliedPriceToSalesAfterDiscountForLackOfMarketabilityMember us-gaap:AvailableforsaleSecuritiesMember 2023-03-31 0001815021 us-gaap:MeasurementInputDiscountForLackOfMarketabilityMember us-gaap:AvailableforsaleSecuritiesMember 2023-03-31 0001815021 us-gaap:MeasurementInputRiskFreeInterestRateMember us-gaap:AvailableforsaleSecuritiesMember srt:MinimumMember 2023-03-31 0001815021 us-gaap:MeasurementInputRiskFreeInterestRateMember us-gaap:AvailableforsaleSecuritiesMember srt:MedianMember 2023-03-31 0001815021 us-gaap:MeasurementInputRiskFreeInterestRateMember us-gaap:AvailableforsaleSecuritiesMember srt:MaximumMember 2023-03-31 0001815021 us-gaap:MeasurementInputPriceVolatilityMember us-gaap:AvailableforsaleSecuritiesMember srt:MinimumMember 2023-03-31 0001815021 us-gaap:MeasurementInputPriceVolatilityMember us-gaap:AvailableforsaleSecuritiesMember srt:MedianMember 2023-03-31 0001815021 us-gaap:MeasurementInputPriceVolatilityMember us-gaap:AvailableforsaleSecuritiesMember srt:MaximumMember 2023-03-31 0001815021 srt:MinimumMember us-gaap:AvailableforsaleSecuritiesMember bq:ProbabilityLiquidationScenarioMember 2023-03-31 0001815021 bq:ProbabilityLiquidationScenarioMember us-gaap:AvailableforsaleSecuritiesMember srt:MaximumMember 2023-03-31 0001815021 bq:ProbabilityRedemptionScenarioMember us-gaap:AvailableforsaleSecuritiesMember srt:MinimumMember 2023-03-31 0001815021 bq:ProbabilityRedemptionScenarioMember us-gaap:AvailableforsaleSecuritiesMember srt:MaximumMember 2023-03-31 0001815021 bq:ProbabilityIpoScenarioMember us-gaap:AvailableforsaleSecuritiesMember srt:MinimumMember 2023-03-31 0001815021 bq:ProbabilityIpoScenarioMember us-gaap:AvailableforsaleSecuritiesMember srt:MaximumMember 2023-03-31 0001815021 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember 2023-03-31 0001815021 bq:QingdaoShuanganBiotechnologyCoLtdMember bq:AvailableForSaleDebtInvestmentsMember 2023-03-31 0001815021 bq:WuhanChunzhijinInformationTechnologyCoLtdMember bq:EquityMethodInvestmentMember 2023-03-31 0001815021 bq:WuhanChunzhijinInformationTechnologyCoLtdMember srt:MaximumMember bq:EquityMethodInvestmentMember 2023-03-31 0001815021 bq:QingdaoShuanganBiotechnologyCoLtdMember 2023-03-31 0001815021 bq:BeijingPetdogTechnologyDevelopmentCoLtdMember 2023-03-31 0001815021 bq:NanjingAnimalPharmaceuticalMember 2023-03-31 0001815021 bq:ContractualArrangementsMember 2023-03-31 0001815021 bq:RepaymentOfLoanMember bq:LoanAgreementsMember 2023-03-31 0001815021 bq:EquityInterestPledgeAgreementsMember 2023-03-31 0001815021 currency:CNY 2023-03-31 0001815021 us-gaap:ShortTermInvestmentsMember 2023-03-31 0001815021 bq:ShortTermBankLoanMember us-gaap:ShortTermInvestmentsMember 2023-03-31 0001815021 bq:ShortTermBankLoanMember 2023-03-31 0001815021 bq:LongTermBankLoanMember us-gaap:ShortTermInvestmentsMember 2023-03-31 0001815021 us-gaap:CommonStockMember 2023-03-31 0001815021 dei:AdrMember 2023-03-31 0001815021 bq:LoanFromChongLiMember 2023-03-31 0001815021 bq:LoanForYokenSeriesAOneWarrantMember 2023-03-31 0001815021 bq:ConversionFeatureOfYokenSeriesAOneWarrantMember 2023-03-31 0001815021 us-gaap:SwapMember 2023-03-31 0001815021 bq:LoanForYokenSeriesAOneWarrantMember bq:YokenSeriesAOneWarrantMember 2023-03-31 0001815021 bq:YokenSeriesAOneWarrantMember 2023-03-31 0001815021 bq:ChongLiMember 2023-03-31 0001815021 bq:CMBMember bq:LongTermLoanFromCmbMember 2023-03-31 0001815021 country:CN 2023-03-31 0001815021 bq:FromOctoberTwoThousandAndTwentyThreeToMarchTwoThousandAndTwentyFourMember bq:LoansReceivablePeriodRangingFromTwelveToTwentyFourMonthsMember 2023-03-31 0001815021 bq:NewForeignExchangeSwapContractMember us-gaap:CurrencySwapMember 2023-03-31 0001815021 bq:LoanReceivableForThePeriodTwentyFourToThirtySixMonthsMember 2023-03-31 0001815021 bq:ProductSalesMember 2020-04-01 2021-03-31 0001815021 bq:OnlineMarketingAndInformationServicesAndOtherRevenueMember 2020-04-01 2021-03-31 0001815021 bq:BeijingPetdogMember 2020-04-01 2021-03-31 0001815021 bq:WeishiNetworkMember 2020-04-01 2021-03-31 0001815021 bq:NanjingAnimalPharmaceuticalMember 2020-04-01 2021-03-31 0001815021 us-gaap:ReceivablesFromStockholderMember 2020-04-01 2021-03-31 0001815021 us-gaap:AdditionalPaidInCapitalMember 2020-04-01 2021-03-31 0001815021 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-04-01 2021-03-31 0001815021 bq:StatutoryReservesMember 2020-04-01 2021-03-31 0001815021 us-gaap:RetainedEarningsMember 2020-04-01 2021-03-31 0001815021 us-gaap:NoncontrollingInterestMember 2020-04-01 2021-03-31 0001815021 us-gaap:CommonStockMember us-gaap:CommonClassBMember 2020-04-01 2021-03-31 0001815021 us-gaap:CommonStockMember us-gaap:CommonClassAMember 2020-04-01 2021-03-31 0001815021 us-gaap:CommonStockMember 2020-04-01 2021-03-31 0001815021 us-gaap:EmployeeStockOptionMember 2020-04-01 2021-03-31 0001815021 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember 2020-04-01 2021-03-31 0001815021 currency:CNY 2020-04-01 2021-03-31 0001815021 us-gaap:AvailableforsaleSecuritiesMember 2020-04-01 2021-03-31 0001815021 us-gaap:SupplierConcentrationRiskMember us-gaap:SalesRevenueNetMember bq:RoyalCaninChinaCoLtdMember 2020-04-01 2021-03-31 0001815021 bq:ThirdPartyMember us-gaap:VariableInterestEntityPrimaryBeneficiaryMember us-gaap:NonrecourseMember 2020-04-01 2021-03-31 0001815021 us-gaap:VariableInterestEntityPrimaryBeneficiaryMember us-gaap:NonrecourseMember 2020-04-01 2021-03-31 0001815021 bq:InterCompanyMember us-gaap:VariableInterestEntityPrimaryBeneficiaryMember us-gaap:NonrecourseMember 2020-04-01 2021-03-31 0001815021 bq:QingdaoShuanganBiotechnologyCoLtdMember 2020-04-01 2021-03-31 0001815021 bq:BeijingPetdogTechnologyDevelopmentCoLtdMember 2020-04-01 2021-03-31 0001815021 bq:RoyalCaninChinaCoLtdMember us-gaap:SupplierConcentrationRiskMember bq:PurchasesMember 2020-04-01 2021-03-31 0001815021 us-gaap:SalesRevenueNetMember 2020-04-01 2021-03-31 0001815021 bq:ProductSalesMember 2021-04-01 2022-03-31 0001815021 bq:OnlineMarketingAndInformationServicesAndOtherRevenueMember 2021-04-01 2022-03-31 0001815021 bq:BeijingPetdogMember 2021-04-01 2022-03-31 0001815021 bq:WeishiNetworkMember 2021-04-01 2022-03-31 0001815021 bq:NanjingAnimalPharmaceuticalMember 2021-04-01 2022-03-31 0001815021 us-gaap:AdditionalPaidInCapitalMember 2021-04-01 2022-03-31 0001815021 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-04-01 2022-03-31 0001815021 bq:StatutoryReservesMember 2021-04-01 2022-03-31 0001815021 us-gaap:RetainedEarningsMember 2021-04-01 2022-03-31 0001815021 us-gaap:ReceivablesFromStockholderMember 2021-04-01 2022-03-31 0001815021 us-gaap:NoncontrollingInterestMember 2021-04-01 2022-03-31 0001815021 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2021-04-01 2022-03-31 0001815021 us-gaap:EmployeeStockOptionMember 2021-04-01 2022-03-31 0001815021 currency:CNY 2021-04-01 2022-03-31 0001815021 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember 2021-04-01 2022-03-31 0001815021 us-gaap:AvailableforsaleSecuritiesMember 2021-04-01 2022-03-31 0001815021 bq:ThirdPartyMember us-gaap:VariableInterestEntityPrimaryBeneficiaryMember us-gaap:NonrecourseMember 2021-04-01 2022-03-31 0001815021 us-gaap:VariableInterestEntityPrimaryBeneficiaryMember us-gaap:NonrecourseMember 2021-04-01 2022-03-31 0001815021 bq:InterCompanyMember us-gaap:VariableInterestEntityPrimaryBeneficiaryMember us-gaap:NonrecourseMember 2021-04-01 2022-03-31 0001815021 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember srt:MinimumMember 2021-04-01 2022-03-31 0001815021 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember srt:MaximumMember 2021-04-01 2022-03-31 0001815021 bq:QingdaoShuanganBiotechnologyCoLtdMember 2021-04-01 2022-03-31 0001815021 bq:NanjingAnimalPharmaceuticalMember 2021-04-01 2022-03-31 0001815021 bq:BeijingPetdogTechnologyDevelopmentCoLtdMember 2021-04-01 2022-03-31 0001815021 us-gaap:EmployeeStockOptionMember 2021-04-01 2022-03-31 0001815021 bq:EmployeesAndNonEmployeesMember 2021-04-01 2022-03-31 0001815021 us-gaap:CurrencySwapMember bq:NewForeignExchangeSwapContractMember 2021-04-01 2022-03-31 0001815021 bq:ExtensionOfLoanAgreementMember bq:CMBMember bq:LongTermLoanFromCmbMember 2021-04-01 2022-03-31 0001815021 bq:NewForeignExchangeSwapContractMember 2021-04-01 2022-03-31 0001815021 bq:ShanghaiGuangchengInformationMember 2021-04-01 2022-03-31 0001815021 bq:RoyalCaninChinaCoLtdMember us-gaap:SupplierConcentrationRiskMember bq:PurchasesMember 2021-04-01 2022-03-31 0001815021 bq:ChongLiMember 2021-04-01 2022-03-31 0001815021 bq:ProductSalesMember 2022-04-01 2023-03-31 0001815021 bq:OnlineMarketingAndInformationServicesAndOtherRevenueMember 2022-04-01 2023-03-31 0001815021 bq:NanjingAnimalPharmaceuticalMember 2022-04-01 2023-03-31 0001815021 bq:WuhanChunzhijinMember 2022-04-01 2023-03-31 0001815021 bq:WeishiNetworkMember 2022-04-01 2023-03-31 0001815021 bq:BeijingPetdogMember 2022-04-01 2023-03-31 0001815021 bq:ShanghaiGuangchengInformationTechnologyLimitedPartnershipshanghaiGuangchengInformationMember 2022-04-01 2023-03-31 0001815021 bq:MerchantTycoonLimitedMember 2022-04-01 2023-03-31 0001815021 bq:SuperbOriginInternationalLimitedMember 2022-04-01 2023-03-31 0001815021 bq:YingzhilisaTangMember 2022-04-01 2023-03-31 0001815021 bq:YanJiangMember 2022-04-01 2023-03-31 0001815021 bq:DijackieChenMember 2022-04-01 2023-03-31 0001815021 bq:YingchristinaZhangMember 2022-04-01 2023-03-31 0001815021 bq:FeiWangMember 2022-04-01 2023-03-31 0001815021 bq:LijunZhouMember 2022-04-01 2023-03-31 0001815021 us-gaap:AdditionalPaidInCapitalMember 2022-04-01 2023-03-31 0001815021 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-04-01 2023-03-31 0001815021 bq:StatutoryReservesMember 2022-04-01 2023-03-31 0001815021 us-gaap:RetainedEarningsMember 2022-04-01 2023-03-31 0001815021 us-gaap:ReceivablesFromStockholderMember 2022-04-01 2023-03-31 0001815021 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2022-04-01 2023-03-31 0001815021 us-gaap:EmployeeStockOptionMember 2022-04-01 2023-03-31 0001815021 bq:ShanghaiEverySupplyChainCoLtdMember 2022-04-01 2023-03-31 0001815021 bq:ShanghaiYiqinPetsProductsCoLtdMember 2022-04-01 2023-03-31 0001815021 bq:XinchengshanghaiInformationTechnologyCoLtdMember 2022-04-01 2023-03-31 0001815021 bq:NanjingXinmuInformationTechnologyCoLtdMember 2022-04-01 2023-03-31 0001815021 bq:XingmuHkLimitedMember 2022-04-01 2023-03-31 0001815021 bq:XingmuInternationalLimitedMember 2022-04-01 2023-03-31 0001815021 bq:BoqiiInternationalLimitedMember 2022-04-01 2023-03-31 0001815021 bq:BoqiiCorporationLimitedMember 2022-04-01 2023-03-31 0001815021 us-gaap:AvailableforsaleSecuritiesMember 2022-04-01 2023-03-31 0001815021 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember 2022-04-01 2023-03-31 0001815021 bq:NanjingXingmuBiotechnologyCoLtdMember 2022-04-01 2023-03-31 0001815021 bq:SuzhouXingyunYuemingSupplyChainCoLtdMember 2022-04-01 2023-03-31 0001815021 bq:BoqiiShanghaiInformationTechnologyCoLtdMember 2022-04-01 2023-03-31 0001815021 bq:TianjingGuangchengInformationTechnologyCoLtdMember 2022-04-01 2023-03-31 0001815021 bq:NanjingCuidaBiotechnologyCoLtdMember 2022-04-01 2023-03-31 0001815021 bq:TaizhouXingmuBiotechnologyCoLtdMember 2022-04-01 2023-03-31 0001815021 bq:GuangchengShanghaiInformationTechnologyCoLtdMember 2022-04-01 2023-03-31 0001815021 bq:SuzhouTaichengSupplyChainCoLtdSuzhouTaichengMember 2022-04-01 2023-03-31 0001815021 bq:ThirdPartyMember us-gaap:VariableInterestEntityPrimaryBeneficiaryMember us-gaap:NonrecourseMember 2022-04-01 2023-03-31 0001815021 us-gaap:NonrecourseMember us-gaap:VariableInterestEntityPrimaryBeneficiaryMember 2022-04-01 2023-03-31 0001815021 bq:InterCompanyMember us-gaap:VariableInterestEntityPrimaryBeneficiaryMember us-gaap:NonrecourseMember 2022-04-01 2023-03-31 0001815021 bq:QingdaoShuanganBiotechnologyCoLtdMember 2022-04-01 2023-03-31 0001815021 bq:NanjingAnimalPharmaceuticalMember 2022-04-01 2023-03-31 0001815021 bq:BeijingPetdogTechnologyDevelopmentCoLtdMember 2022-04-01 2023-03-31 0001815021 bq:WarehouseEquipmentMember srt:MinimumMember 2022-04-01 2023-03-31 0001815021 srt:MaximumMember bq:WarehouseEquipmentMember 2022-04-01 2023-03-31 0001815021 us-gaap:FurnitureAndFixturesMember srt:MinimumMember 2022-04-01 2023-03-31 0001815021 us-gaap:FurnitureAndFixturesMember srt:MaximumMember 2022-04-01 2023-03-31 0001815021 us-gaap:VehiclesMember 2022-04-01 2023-03-31 0001815021 bq:SoftwareMember 2022-04-01 2023-03-31 0001815021 us-gaap:LeaseholdImprovementsMember 2022-04-01 2023-03-31 0001815021 us-gaap:TrademarksMember 2022-04-01 2023-03-31 0001815021 us-gaap:DistributionRightsMember 2022-04-01 2023-03-31 0001815021 us-gaap:LicenseMember 2022-04-01 2023-03-31 0001815021 bq:EmployeesAndNonEmployeesMember 2022-04-01 2023-03-31 0001815021 srt:MinimumMember country:HK 2022-04-01 2023-03-31 0001815021 country:HK srt:MaximumMember 2022-04-01 2023-03-31 0001815021 country:CN 2022-04-01 2023-03-31 0001815021 dei:BusinessContactMember 2022-04-01 2023-03-31 0001815021 dei:AdrMember 2022-04-01 2023-03-31 0001815021 us-gaap:CommonClassAMember 2022-04-01 2023-03-31 0001815021 bq:ChongniNetworkTechnologyCoLtdMember 2022-04-01 2023-03-31 0001815021 us-gaap:CommonClassBMember 2022-04-01 2023-03-31 0001815021 bq:SeriesCRedeemableConvertiblePreferredSharesMember 2022-04-01 2023-03-31 0001815021 us-gaap:CurrencySwapMember bq:NewForeignExchangeSwapContractMember 2022-04-01 2023-03-31 0001815021 us-gaap:TaxYear2018Member 2022-04-01 2023-03-31 0001815021 us-gaap:NoncontrollingInterestMember 2022-04-01 2023-03-31 0001815021 bq:LongTermLoanFromCmbMember bq:CMBMember bq:ExtensionOfLoanAgreementMember 2022-04-01 2023-03-31 0001815021 bq:NewForeignExchangeSwapContractMember 2022-04-01 2023-03-31 0001815021 bq:RoyalCaninChinaCoLtdMember us-gaap:SupplierConcentrationRiskMember bq:PurchasesMember 2022-04-01 2023-03-31 0001815021 srt:MaximumMember bq:FromOctoberTwoThousandAndTwentyThreeToMarchTwoThousandAndTwentyFourMember bq:LoansReceivablePeriodRangingFromTwelveToTwentyFourMonthsMember 2022-04-01 2023-03-31 0001815021 bq:LoansReceivablePeriodRangingFromTwelveToTwentyFourMonthsMember bq:FromOctoberTwoThousandAndTwentyThreeToMarchTwoThousandAndTwentyFourMember srt:MinimumMember 2022-04-01 2023-03-31 0001815021 bq:LoansReceivablePeriodRangingFromTwelveToTwentyFourMonthsMember srt:MinimumMember 2022-04-01 2023-03-31 0001815021 bq:LoansReceivablePeriodRangingFromTwelveToTwentyFourMonthsMember srt:MaximumMember 2022-04-01 2023-03-31 0001815021 bq:FromMayTwoThousandAndTwentyOneToMayTwoThousandAndTwentyTwoMember bq:LoanReceivableForThePeriodTwentyFourToThirtySixMonthsMember srt:MinimumMember 2022-04-01 2023-03-31 0001815021 bq:FromMayTwoThousandAndTwentyOneToMayTwoThousandAndTwentyTwoMember bq:LoanReceivableForThePeriodTwentyFourToThirtySixMonthsMember srt:MaximumMember 2022-04-01 2023-03-31 0001815021 bq:ChongLiMember 2022-04-01 2023-03-31 0001815021 country:CN bq:DomesticEnterpriseMember bq:StatutorySurplusReserveMember 2022-04-01 2023-03-31 0001815021 country:CN 2022-04-01 2023-03-31 0001815021 bq:QingdaoShuanganMember 2022-04-01 2023-03-31 0001815021 us-gaap:DiscontinuedOperationsDisposedOfBySaleMember 2022-04-01 2023-03-31 0001815021 bq:IntellectualPropertyLicenseAgreementsMember 2023-03-31 2023-03-31 0001815021 bq:LoanAgreementMember bq:ShanghaiGuangchengInformationMember 2021-04-01 0001815021 bq:ShanghaiGuangchengInformationMember 2021-04-01 0001815021 bq:ChongniNetworkTechnologyCoLtdMember 2018-10-31 0001815021 bq:ChongniNetworkTechnologyCoLtdMember 2021-06-30 2021-06-30 0001815021 bq:BetterChoiceCompanyIncMember 2021-06-30 2021-06-30 0001815021 bq:ChongniNetworkTechnologyCoLtdMember 2021-06-30 0001815021 bq:XingmuGroupMember 2021-06-30 0001815021 bq:NanjingCuidaBiotechnologyCoLtdMember 2021-06-30 2022-03-31 0001815021 bq:JiangsuNanjingAgriculturalUniversityAnimalPharmaceuticalCoLtdMember 2019-04-01 2019-04-30 0001815021 bq:BeijingPetdogTechnologyDevelopmentCoLtdMember 2019-10-01 2019-10-31 0001815021 bq:NanjingAnimalPharmaceuticalMember 2021-07-31 2021-07-31 0001815021 bq:NanjingAnimalPharmaceuticalMember 2021-07-31 0001815021 bq:NanjingAnimalPharmaceuticalMember bq:AccruedLiabilitiesAndOtherCurrentLiabilitiesMember 2021-07-31 0001815021 bq:WuhanChunzhijinMember 2021-03-31 0001815021 bq:MerchantTycoonLimitedMember 2021-03-31 0001815021 bq:YingzhilisaTangMember 2021-03-31 0001815021 bq:LijunZhouMember 2021-03-31 0001815021 bq:YanJiangMember 2021-03-31 0001815021 bq:NanjingAnimalPharmaceuticalMember 2021-03-31 0001815021 bq:FeiWangMember 2021-03-31 0001815021 bq:ShanghaiGuangchengInformationMember 2021-03-31 0001815021 bq:SuperbOriginInternationalLimitedMember 2021-03-31 0001815021 bq:AdsMember us-gaap:IPOMember 2020-10-01 2020-10-31 0001815021 bq:AdsMember us-gaap:OverAllotmentOptionMember 2020-10-01 2020-10-31 0001815021 us-gaap:CommonClassAMember 2020-10-01 2020-10-31 0001815021 us-gaap:IPOMember bq:SeriesARedeemableConvertiblePreferredSharesMember 2020-10-01 2020-10-31 0001815021 us-gaap:IPOMember bq:SeriesBRedeemableConvertiblePreferredSharesMember 2020-10-01 2020-10-31 0001815021 us-gaap:IPOMember bq:SeriesCPlusRedeemableConvertiblePreferredSharesMember 2020-10-01 2020-10-31 0001815021 us-gaap:IPOMember us-gaap:CommonClassBMember 2020-10-01 2020-10-31 0001815021 bq:AdsMember 2020-10-31 0001815021 us-gaap:IPOMember us-gaap:CommonClassAMember 2020-10-31 0001815021 us-gaap:CommonClassBMember 2020-10-31 0001815021 bq:SeriesARedeemableConvertiblePreferredSharesMember us-gaap:IPOMember 2020-10-31 0001815021 us-gaap:IPOMember bq:SeriesBRedeemableConvertiblePreferredSharesMember 2020-10-31 0001815021 us-gaap:IPOMember bq:SeriesCPlusRedeemableConvertiblePreferredSharesMember 2020-10-31 0001815021 us-gaap:SeriesCPreferredStockMember us-gaap:IPOMember 2020-10-31 0001815021 us-gaap:IPOMember us-gaap:CommonClassAMember 2021-02-01 2021-02-28 0001815021 bq:YokenHoldingLimitedMember 2020-10-31 2020-10-31 0001815021 bq:LoanForYokenSeriesAOneWarrantMember 2020-03-31 2020-03-31 0001815021 bq:CMBMember bq:LongTermLoanFromCmbMember 2020-03-31 2020-03-31 0001815021 bq:LoanForYokenSeriesAOneWarrantMember 2020-03-31 0001815021 bq:LongTermLoanFromCmbMember bq:CMBMember 2020-03-31 0001815021 bq:ExtensionOfLoanAgreementMember bq:CMBMember bq:LongTermLoanFromCmbMember 2020-03-31 0001815021 bq:ChongLiMember 2020-03-31 0001815021 bq:SuperbOriginInternationalLimitedMember bq:ChongLiMember bq:EquityOwnerMember 2020-03-31 0001815021 bq:LoanForYokenSeriesAOneWarrantMember 2020-10-23 2020-10-23 0001815021 bq:YokenSeriesAOneWarrantMember bq:InvestorTwoMember 2020-10-23 2020-10-23 0001815021 bq:InvestorOneMember bq:YokenSeriesAOneWarrantMember 2020-10-23 2020-10-23 0001815021 bq:InvestorOneMember bq:YokenSeriesAOneWarrantMember 2020-10-23 0001815021 bq:YokenSeriesAOneWarrantMember bq:InvestorTwoMember 2020-10-23 0001815021 bq:YokenSeriesAOneWarrantMember 2020-10-23 0001815021 bq:LoanForYokenSeriesAOneWarrantMember bq:YokenSeriesAOneWarrantMember 2021-03-31 2021-03-31 0001815021 us-gaap:SubsequentEventMember bq:NanjingAnimalPharmaceuticalMember 2023-04-30 2023-04-30 0001815021 bq:JiangsuNanjingAgriculturalUniversityAnimalPharmaceuticalCoLtdMember bq:EquityMethodInvestmentMember 2019-04-30 0001815021 bq:BeijingPetdogTechnologyDevelopmentCoLtdMember bq:AvailableForSaleDebtInvestmentsMember 2019-10-31 0001815021 bq:NanjingAgriculturalPharmaceuticalMember bq:TwelveMonthInterestFreeLoanAgreementMember 2019-12-31 0001815021 bq:OneYearLoanAgreementMember bq:FeiWangMember 2021-01-31 0001815021 bq:TwoThousandTwelveGlobalSharePlanMember 2012-09-27 0001815021 bq:TwoThousandEighteenGlobalSharePlanMember 2018-08-01 0001815021 bq:TwoThousandEighteenGlobalSharePlanMember 2020-09-01 0001815021 bq:AmendedTwoThousandEighteenGlobalSharePlanMember 2020-09-01 0001815021 bq:ChongLiMember 2020-03-01 0001815021 bq:TwelveMonthInterestFreeLoanAgreementMember bq:NanjingAgriculturalPharmaceuticalMember 2020-06-30 0001815021 bq:EquityMethodInvestmentMember bq:WuhanChunzhijinInformationTechnologyCoLtdMember 2020-04-30 0001815021 bq:CMBMember bq:LongTermLoanFromCmbMember 2020-03-01 2020-03-31 0001815021 bq:TwoThousandEighteenGlobalSharePlanMember 2022-05-31 0001815021 bq:AmendedTwoThousandEighteenGlobalSharePlanMember 2022-05-31 0001815021 us-gaap:CommonStockMember 2020-03-31 0001815021 us-gaap:ReceivablesFromStockholderMember 2020-03-31 0001815021 us-gaap:NoncontrollingInterestMember 2020-03-31 0001815021 us-gaap:RetainedEarningsMember 2020-03-31 0001815021 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-03-31 0001815021 bq:StatutoryReservesMember 2020-03-31 0001815021 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember 2020-03-31 0001815021 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember 2021-03-31 0001815021 us-gaap:AvailableforsaleSecuritiesMember 2020-03-31 0001815021 us-gaap:CommonStockMember us-gaap:CommonClassBMember 2021-03-31 0001815021 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2021-03-31 0001815021 us-gaap:AdditionalPaidInCapitalMember 2021-03-31 0001815021 bq:StatutoryReservesMember 2021-03-31 0001815021 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-03-31 0001815021 us-gaap:RetainedEarningsMember 2021-03-31 0001815021 us-gaap:NoncontrollingInterestMember 2021-03-31 0001815021 us-gaap:ReceivablesFromStockholderMember 2021-03-31 0001815021 us-gaap:AvailableforsaleSecuritiesMember 2021-03-31 0001815021 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember 2022-03-31 0001815021 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2022-03-31 0001815021 us-gaap:CommonStockMember us-gaap:CommonClassAMember 2022-03-31 0001815021 us-gaap:AdditionalPaidInCapitalMember 2022-03-31 0001815021 bq:StatutoryReservesMember 2022-03-31 0001815021 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-03-31 0001815021 us-gaap:RetainedEarningsMember 2022-03-31 0001815021 us-gaap:NoncontrollingInterestMember 2022-03-31 0001815021 us-gaap:ReceivablesFromStockholderMember 2022-03-31 0001815021 us-gaap:AvailableforsaleSecuritiesMember 2022-03-31 0001815021 us-gaap:CommonStockMember us-gaap:CommonClassAMember 2023-03-31 0001815021 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2023-03-31 0001815021 us-gaap:AdditionalPaidInCapitalMember 2023-03-31 0001815021 bq:StatutoryReservesMember 2023-03-31 0001815021 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-03-31 0001815021 us-gaap:RetainedEarningsMember 2023-03-31 0001815021 us-gaap:NoncontrollingInterestMember 2023-03-31 0001815021 us-gaap:ReceivablesFromStockholderMember 2023-03-31 0001815021 us-gaap:AvailableforsaleSecuritiesMember 2023-03-31 iso4217:USD iso4217:CNY xbrli:shares utr:Year iso4217:HKD iso4217:EUR iso4217:NZD xbrli:pure utr:Month utr:Day iso4217:USD xbrli:shares iso4217:CNY xbrli:shares
 
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
 
FORM
20-F
 
 
(Mark One)
REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934
OR
 
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the fiscal year ended March 31, 2023.
OR
 
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
OR
 
SHELL COMPANY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
Date of event requiring this shell company report
                    
For the transition period from
    
    
        
    
to
    
        
    
    
Commission file number:
001-39547
 
 
BOQII HOLDING LIMITED
(Exact name of Registrant as specified in its charter)
 
 
N/A
(Translation of Registrant’s name into English)
Cayman Islands
(Jurisdiction of incorporation or organization)
Building 9, No. 388, Shengrong Road
Pudong New District, Shanghai 201210
People’s Republic of China
(Address of principal executive offices)
Yingzhi (Lisa) Tang
Chief Financial Officer
Tel: +86 180 1851 3366
E-mail:
lisa@boqii.com
Building 9, No. 388, Shengrong Road
Pudong New District, Shanghai 201210
People’s Republic of China
(Name, Telephone,
E-mail
and/or Facsimile number and Address of Company Contact Person)
 
 
Securities registered or to be registered pursuant to Section 12(b) of the Act:
 
Title of each class
 
Trading Symbol
 
Name of each exchange on which registered
American depositary shares, each ADS represents four and one half (4.5) Class A ordinary shares, par value US$0.001 per share
 
BQ
 
The New York Stock Exchange
Class A ordinary shares, par value US$0.001 per share*
 
N/A
 
The New York Stock Exchange
 
*
Not for trading, but only in connection with the listing of the American depositary shares on the New York Stock Exchange.
Securities registered or to be registered pursuant to Section 12(g) of the Act:
None
(Title of Class)
Securities for which there is a reporting obligation pursuant to Section 15(d) of the Act:
None
(Title of Class)
 
 
Indicate the number of outstanding shares of each of the issuer’s classes of capital or common stock as of the close of the period covered by the annual report.
As of March 31, 2023, there were 70,729,482 ordinary shares outstanding, being the sum of 57,691,753 Class A ordinary shares, including 1,928,662 Class A ordinary shares held by the depositary bank underlying the options granted but not yet exercised under the Amended and Restated 2018 Global Share Plan, and 13,037,729 Class B ordinary shares.
Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.
Yes  ☐            No  ☒
If this report is an annual or transition report, indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.
Yes  ☐            No  ☒
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
Yes  ☒            No  ☐
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation
S-T
(§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).
Yes  ☒            No  ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, or a
non-accelerated
filer, or an emerging growth company. See definition of “large accelerated filer,” “accelerated filer,” and “emerging growth company” in Rule
12b-2
of the Exchange Act.
 
Large Accelerated Filer
 
 
Accelerated Filer
 
  
Non-accelerated Filer
 
 
 
 
  
Emerging growth company
 
If an emerging growth company that prepares its financial statements in accordance with U.S. GAAP, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards † provided pursuant to Section 13(a) of the Exchange Act.  
 
The term “new or revised financial accounting standard” refers to any update issued by the Financial Accounting Standards Board to its Accounting Standards Codification after April 5, 2012.
Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report.  
If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements.  ☐
Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant’s executive officers during the relevant recovery period pursuant to
§240.10D-1(b).  ☐
Indicate by check mark which basis of accounting the registrant has used to prepare the financial statements included in this filing:
 
 
U.S. GAAP
 
 
International Financial Reporting Standards as issued by the International Accounting Standards Board
 
 
Other
If “Other” has been checked in response to the previous question, indicate by check mark which financial statement item the registrant has elected to follow.
☐  Item 17            ☐  Item 18
If this is an annual report, indicate by check mark whether the registrant is a shell company (as defined in Rule
12b-2
of the Exchange Act).
Yes  ☐            No  
(APPLICABLE ONLY TO ISSUERS INVOLVED IN BANKRUPTCY PROCEEDINGS DURING THE PAST FIVE YEARS)
Indicate by check mark whether the registrant has filed all documents and reports required to be filed by Sections 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court.
Yes  ☐            No  ☐
 
 
 


Table of Contents

TABLE OF CONTENTS

 

INTRODUCTION      1  
FORWARD-LOOKING INFORMATION      2  
PART I      2  
ITEM 1. IDENTITY OF DIRECTORS, SENIOR MANAGEMENT AND ADVISERS      2  
ITEM 2. OFFER STATISTICS AND EXPECTED TIMETABLE      3  
ITEM 3. KEY INFORMATION      3  
ITEM 4. INFORMATION ON THE COMPANY      65  
ITEM 4A. UNRESOLVED STAFF COMMENTS      95  
ITEM 5. OPERATING AND FINANCIAL REVIEW AND PROSPECTS      95  
ITEM 6. DIRECTORS, SENIOR MANAGEMENT AND EMPLOYEES      107  
ITEM 7. MAJOR SHAREHOLDERS AND RELATED PARTY TRANSACTIONS      114  
ITEM 8. FINANCIAL INFORMATION      115  
ITEM 9. THE OFFER AND LISTING      116  
ITEM 10. ADDITIONAL INFORMATION      116  
ITEM 11. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK      122  
ITEM 12. DESCRIPTION OF SECURITIES OTHER THAN EQUITY SECURITIES      123  
PART II      124  
ITEM 13. ITEM DEFAULTS, DIVIDEND ARREARAGES AND DELINQUENCIES      124  
ITEM 14. MATERIAL MODIFICATIONS TO THE RIGHTS OF SECURITY HOLDERS AND USE OF PROCEEDS      124  
ITEM 15. CONTROLS AND PROCEDURES      125  
ITEM 16.A. AUDIT COMMITTEE FINANCIAL EXPERT      126  
ITEM 16.B. CODE OF ETHICS      126  
ITEM 16.C. PRINCIPAL ACCOUNTANT FEES AND SERVICES      126  
ITEM 16.D. EXEMPTIONS FROM THE LISTING STANDARDS FOR AUDIT COMMITTEES      127  
ITEM 16.E. PURCHASES OF EQUITY SECURITIES BY THE ISSUER AND AFFILIATED PURCHASERS      127  
ITEM 16.F. CHANGE IN REGISTRANT’S CERTIFYING ACCOUNTANT      127  
ITEM 16.G. CORPORATE GOVERNANCE      127  
ITEM 16.H. MINE SAFETY DISCLOSURE      127  
ITEM 16.I. DISCLOSURE REGARDING FOREIGN JURISDICTIONS THAT PREVENT INSPECTIONS      128  
ITEM 16.J. INSIDER TRADING POLICIES      128  
PART III      128  
ITEM 17. FINANCIAL STATEMENTS      128  
ITEM 18. FINANCIAL STATEMENTS      128  
ITEM 19. EXHIBITS      129  


Table of Contents

INTRODUCTION

Except where the context otherwise indicates and for the purpose of this annual report only:

 

   

“ADSs” refers to the American depositary shares, each representing 4.5 Class A ordinary shares;

 

   

“Boqii,” “we,” “us,” “our company,” “the Company,” “the Group” and “our” refer to Boqii Holding Limited, a Cayman Islands exempted company and its subsidiaries and, in the context of describing our operations and consolidated financial information, the VIEs and their respective subsidiaries;

 

   

“brand owner” refers to a company engaging in the production and sale of branded pet goods;

 

   

“brand partner” refers to a specific brand owner whose products are sold via our online sales platforms and offline network;

 

   

“CAGR” refers to compound annual growth rate;

 

   

“Class A ordinary shares” refers to our Class A ordinary shares, par value US$0.001 per share;

 

   

“Class B ordinary shares” refers to our Class B ordinary shares, par value US$0.001 per share;

 

   

“China” or “the PRC” refers to the People’s Republic of China, including Hong Kong and Macau and, only for the purpose of this annual report, excluding Taiwan; the only instances in which “China” or “the PRC” do not include Hong Kong or Macau are when used in the case of laws and regulations, including, among others, tax matters, adopted by the People’s Republic of China; the legal and operational risks associated with operating in China also apply to our operations in Hong Kong;

 

   

“GMV” refers to gross merchandise volume, which is the total value of confirmed orders placed with us and sold through distribution model or drop shipping model where we act as a principal in the transaction regardless of whether the products are delivered or returned, calculated based on the listed prices of the ordered products without taking into consideration any discounts. With respect to products sold by Xingmu, such GMV is calculated based on the suggested retail prices of the ordered products without taking into consideration any discounts and regardless of whether the products are delivered or returned. For the avoidance of doubt, the total GMV amounts disclosed in this annual report (i) includes GMV of products sold by Xingmu, (ii) excludes products sold through consignment model and (iii) excludes the value of services offered by us;

 

   

“KOL” refers to key opinion leaders, or individuals who have the power to engage and impact people within a specific community or field;

 

   

“MAU” refers to monthly active user, or the aggregate number of unique devices that were used to access our online platforms at least once in a given month. Our MAUs are calculated using internal company data, treating each distinguishable device as a separate MAU even though some users may access our platforms using more than one device and multiple users may access our platforms using the same device;

 

   

“online platforms” refers to our online sales platforms and our content platform;

 

   

“online sales platforms” refer to Boqii Mall, our flagship stores on third-party e-commerce platforms and our proprietary SaaS system;

 

   

“Post-IPO MAA” means the twelfth amended and restated memorandum and articles of association of our company currently effective;

 

   

“Meiyizhi WFOE” refers to Shanghai Meiyizhi Supply Chain Co., Ltd.;

 

   

“RMB” or “Renminbi” refers to the legal currency of the People’s Republic of China;

 

   

“Shanghai Guangcheng” refers to Guangcheng (Shanghai) Information Technology Co., Ltd.;

 

   

“Shanghai Xincheng” refers to Xincheng (Shanghai) Information Technology Co., Ltd.;

 

   

“shares” or “ordinary shares” refers to our Class A and Class B ordinary shares, par value US$0.001 per share;

 

   

“Suzhou Taicheng” refers to Suzhou Taicheng Supply Chain Co., Ltd.;

 

   

“Suzhou Xingyun” refers to Suzhou Xingyun Yueming Supply Chain Co., Ltd.;

 

   

“US$,” “dollars” or “U.S. dollars” refers to the legal currency of the United States;

 

   

“variable interest entities,” or “VIEs,” refers to the PRC entities of which we have power to control the management, and financial and operating policies and have the right to recognize and receive substantially all the economic benefits and in which we have an exclusive option to purchase all or part of the equity interests at the minimum price possible to the extent permitted by PRC law;

 

1


Table of Contents
   

“Xingmu” or “Nanjing Xingmu” refers to Nanjing Xingmu Biotechnology Co., Ltd.;

 

   

“Xingmu WFOE” refers to Nanjing Xinmu Information Technology Co., Ltd.; and

 

   

“Yoken WFOE” refers to Chengdu Chongaita Information Technology Co., Ltd.

Unless otherwise noted, all translations from Renminbi to U.S. dollars and from U.S. dollars to Renminbi in this annual report are made at RMB6.8676 to US$1.00, the exchange rate set forth in the H.10 statistical release of the Federal Reserve Board on March 31, 2023. We make no representation that any Renminbi or U.S. dollar amounts could have been, or could be, converted into U.S. dollars or Renminbi, as the case may be, at any particular rate, the rates stated below, or at all.

FORWARD-LOOKING INFORMATION

This annual report contains statements that constitute forward-looking statements. These statements are made under the “safe harbor” provisions of the U.S. Private Securities Litigations Reform Act of 1995. Many of the forward-looking statements contained in this annual report can be identified by the use of forward-looking words such as “anticipate,” “believe,” “could,” “expect,” “should,” “plan,” “intend,” “estimate” and “potential,” among others.

Forward-looking statements appear in a number of places in this annual report and include, but are not limited to, statements regarding our intent, belief or current expectations. Forward-looking statements are based on our management’s beliefs and assumptions and on information currently available to our management. Such statements are subject to risks and uncertainties, and actual results may differ materially from those expressed or implied in the forward-looking statements due to various factors, including, but not limited to, those identified under the section entitled “Item 3. Key Information—3.D. Risk Factors” in this annual report. These risks and uncertainties include factors relating to:

 

   

our mission and strategies;

 

   

our future business development, financial conditions and results of operations;

 

   

the expected growth of the online retail and pet industries in China;

 

   

our expectations regarding demand for and market acceptance of our products and services;

 

   

our expectations regarding keeping and strengthening our relationships with customers, users, KOLs, brand partners, manufacturers, strategic partners, offline pet stores and pet hospitals and other stakeholders;

 

   

competition in our industry;

 

   

general economic and business condition in China; and

 

   

relevant government policies and regulations relating to our industry.

This annual report contains certain data and information that we obtained from various government and private publications. Statistical data in these publications also include projections based on a number of assumptions. Our industry may not grow at the rate projected by market data, or at all. Failure of this market to grow at the projected rate may have a material and adverse effect on our business and the market price of our ADSs. In addition, the rapidly changing nature of pet industry results in significant uncertainties for any projections or estimates relating to the growth prospects or future condition of our market. Furthermore, if any one or more of the assumptions underlying the market data are later found to be incorrect, actual results may differ from the projections based on these assumptions. You should not place undue reliance on these forward-looking statements.

Forward-looking statements speak only as of the date they are made, and except to the extent required by applicable laws and regulations, we do not undertake any obligation to update them in light of new information or future developments or to release publicly any revisions to these statements in order to reflect later events or circumstances or to reflect the occurrence of unanticipated events.

PART I

 

ITEM 1.

IDENTITY OF DIRECTORS, SENIOR MANAGEMENT AND ADVISERS

Not applicable.

 

2


Table of Contents
ITEM 2.

OFFER STATISTICS AND EXPECTED TIMETABLE

Not applicable.

 

ITEM 3.

KEY INFORMATION

Holding Company Structure

Boqii Holding Limited is a Cayman Islands holding company with no business operations. The Company conducts its operations in China through its PRC subsidiaries and the consolidated variable interest entities, or the VIEs, and the VIEs’ subsidiaries. The Company, its shareholders who are non-PRC residents and its subsidiaries do not and are not legally permitted to have any equity interests in the VIEs as current PRC laws and regulations restrict foreign investment in companies that engage in value-added telecommunication services and certain other restricted services related to our businesses. As a result, the Company operates relevant businesses in China through certain contractual arrangements by and among the WFOEs, the VIEs and the respective shareholders of the VIEs. This structure allows the WFOEs to exercise effective control over the VIEs, and be considered the primary beneficiary of the VIEs, which serves the purpose of consolidating the VIEs’ operating results in the Company’s financial statements under the U.S. GAAP. This structure also provides contractual exposure to foreign investment in such companies. As of the date of this annual report, to the best knowledge of our Company, our directors and management, the VIE agreements have not been tested in a court of law in the PRC. Investors in the Company’s ADSs are purchasing equity securities of a Cayman Islands holding company rather than equity securities issued by the Company’s subsidiaries and the VIEs. Investors who are non-PRC residents may not directly hold equity interests in the VIEs under current PRC laws and regulations.

Our corporate structure involves unique risks to investors in the ADSs. For the fiscal years ended March 31, 2021, 2022 and 2023, the amount of revenues generated by the VIEs accounted for 77.5%, 78.7% and 79.9%, respectively, of our total net revenues. As of March 31, 2021, 2022 and 2023, total assets of the VIEs, excluding amounts due from other companies in our Company, equaled to 24.5%, 34.2% and 43.9% of our consolidated total assets as of the same dates, respectively. If the PRC government deems that our contractual arrangements with the VIEs do not comply with PRC regulatory restrictions on foreign investment in the relevant industries, or if these regulations or the interpretation of existing regulations change in the future, we could be subject to material penalties or be forced to relinquish our interests in those operations or otherwise significantly change our corporate structure. We and our investors face significant uncertainty about potential future actions by the PRC government that could affect the legality and enforceability of the contractual arrangements with the VIEs and, consequently, significantly affect the financial performance of our company as a whole. Our ADSs may decline in value or become worthless, if we are unable to claim our contractual control rights over the assets of the VIEs that conduct substantially all of our operations in China. For detailed discussion, see “Item 3. Key Information—3.D. Risk Factors—Risks Related to Our Corporate Structure and Contractual Arrangements.” The following diagram illustrates our corporate structure, including our principal subsidiaries and VIEs, as of the date of this annual report.

 

LOGO

 

3


Table of Contents

Notes:

 

LOGO   Equity interest
LOGO   Contractual arrangements, including the exclusive technical consulting and service agreement, intellectual property license agreement, equity pledge agreement, exclusive call option agreement, shareholders’ voting rights proxy agreement and loan agreement. See “—Contractual Arrangements with the VIEs and Their Respective Shareholders.”

Contractual Arrangements with the VIEs and Their Respective Shareholders

Current PRC laws and regulations impose certain restrictions or prohibitions on foreign ownership of companies that engage in value-added telecommunication services. We are an exempted company with limited liability incorporated in the Cayman Islands and our wholly owned PRC subsidiaries are currently considered foreign-invested enterprise. Accordingly, our PRC subsidiaries are not eligible to provide value-added telecommunication services in China or import veterinary drugs. To ensure strict compliance with the PRC laws and regulations, we conduct such business activities through the VIEs, Suzhou Taicheng, Shanghai Guangcheng, Nanjing Xingmu and Suzhou Xingyun. Shanghai Xincheng, Xingmu WFOE and Meiyizhi WFOE, our wholly owned subsidiaries in China, have entered into a series of contractual arrangements with the VIEs and their respective shareholders, which enable us to (i) exercise effective control over the VIEs, (ii) receive substantially all of the economic benefits of the VIEs, and (iii) have an exclusive option to purchase all or part of the equity interests in the VIEs when and to the extent permitted by PRC law. These contractual arrangements include the exclusive consultation and technical service agreement, loan agreements, equity pledge agreement, exclusive purchase option agreement, shareholder voting right trust agreement, and spousal consents, as the case may be. As a result of these contractual arrangements, we exert effective control over, and are considered the primary beneficiary of, the VIEs and consolidate its operating results in our financial statements under U.S. GAAP.

The following is a summary of the major terms of the contractual arrangements by and among Shanghai Xincheng, Shanghai Guangcheng and the shareholders of Shanghai Guangcheng. The contractual arrangements by and among Xingmu WFOE, Nanjing Xingmu and the shareholders of Nanjing Xingmu, the contractual arrangements by and among Shanghai Xincheng, Suzhou Taicheng and the shareholders of Suzhou Taicheng, and the contractual arrangements by and among Meiyizhi WFOE, Suzhou Xingyun and the shareholders of Suzhou Xingyun are substantially similar to the corresponding contractual arrangements discussed below, unless otherwise indicated.

Exclusive Technical Consulting and Service Agreement

Pursuant to an exclusive technical consulting and service agreement entered into on August 4, 2020 by and between Shanghai Xincheng and Shanghai Guangcheng, Shanghai Guangcheng agreed to appoint Shanghai Xincheng as its exclusive provider of consulting and services related to, among other things, e-commerce platform design and maintenance, business consulting, internal training, labor support, market research and development, strategic planning and customer support and development. In exchange, Shanghai Guangcheng agrees to pay Shanghai Xincheng an annual service fee, at an amount that is agreed by both parties. This agreement will remain effective unless Shanghai Xincheng and Shanghai Guangcheng terminate this agreement in writing.

Intellectual Property License Agreement

Pursuant to an intellectual property license agreement entered into on August 4, 2020 by and between Shanghai Xincheng and Shanghai Guangcheng, Shanghai Xincheng agreed to grant to Shanghai Guangcheng a nonsublicensable, nontransferable and nonexclusive license of certain intellectual properties solely for Shanghai Guangcheng’s use. In exchange, Shanghai Guangcheng agrees to pay a royalty, at an amount that is agreed by both parties. The term of this agreement is ten years from the date of such agreement and will be automatically extended for another ten-year term unless it is terminated by three months’ written notice by the licensor.

Shareholders’ Voting Rights Proxy Agreement

Pursuant to the shareholders’ voting rights proxy agreement entered into on August 4, 2020, by and among Shanghai Xincheng, Shanghai Guangcheng, and then shareholders of Shanghai Guangcheng, as supplemented from time to time, such shareholders of Shanghai Guangcheng irrevocably authorized the person then designated by Shanghai Xincheng to exercise such shareholders’ rights in Shanghai Guangcheng, including without limitation, the power to participate in and vote at shareholders’ meetings, the power to nominate and appoint the directors, senior management, the power to propose to convene a shareholders’ meeting, and other shareholders’ voting rights permitted by the Articles of Association of Shanghai Guangcheng.

 

4


Table of Contents

Equity Pledge Agreement

Pursuant to an equity pledge agreement entered on October 16, 2019, by and between Shanghai Xincheng, Shanghai Guangcheng, and then shareholders of Shanghai Guangcheng, as supplemented by an equity pledge agreement entered into on August 4, 2020 and an equity pledge agreement entered into on September 25, 2022, by and between Shanghai Xincheng, Shanghai Guangcheng, and Shanghai Chelin Information Technology Center (Limited Partnership), a then shareholder of Shanghai Guangcheng, such shareholders of Shanghai Guangcheng pledged all of their equity interests in Shanghai Guangcheng to Shanghai Xincheng, to guarantee the performance of Shanghai Guangcheng, and, to the extent applicable, such shareholders of Shanghai Guangcheng, or their obligations under the contractual arrangements of the VIEs. If Shanghai Guangcheng or such shareholders fail to perform their obligations under the contractual arrangement of the VIEs, Shanghai Xincheng will be entitled to, among other things, the right to sell the pledged equity interests in Shanghai Guangcheng. The shareholders of Shanghai Guangcheng also undertake that, during the term of the equity pledge agreement, they will not dispose of the pledged equity interests or create or allow any encumbrance on the pledged equity interests without prior written consent of Shanghai Xincheng. As of the date of this annual report, the equity pledges under the share pledge agreements have been registered with the relevant PRC legal authority pursuant to PRC laws and regulations.

As of the date of this annual report, all equity pledges under the share pledge agreements by and between the shareholders of Nanjing Xingmu and Xingmu WFOE, by and between the shareholders of Suzhou Xingyun and Meiyizhi WFOE, as well as by and between the shareholders of Suzhou Taicheng and Shanghai Xincheng have been registered with the relevant PRC legal authority pursuant to PRC laws and regulations.

Exclusive Call Option Agreement

Pursuant to an exclusive call option agreement entered on August 4, 2020, by and between Shanghai Xincheng, Shanghai Guangcheng and then shareholders of Shanghai Guangcheng, as supplemented from time to time, such shareholders of Shanghai Guangcheng irrevocably and unconditionally granted Shanghai Xincheng an exclusive call option to purchase, or have its designated person(s) to purchase, at its discretion, all or part of the equity options in Shanghai Guangcheng. The purchase price shall be the lowest price permitted by applicable PRC laws and regulations. The shareholders of Shanghai Guangcheng undertake that, without the prior written consent of Shanghai Xincheng, they may not increase or decrease the registered capital or conduct any merger, transfer or dispose of their equity options and any other third-party rights thereon, dispose of, or procure the management to dispose of, material assets of Shanghai Guangcheng, terminate or procure the management to terminate any material agreements or enter into any agreements in conflict with any existing material agreement, appoint or dismiss any director, supervisor or any other senior management which should be appointed or dismissed by such shareholders, procure Shanghai Guangcheng to declare or distribute any distributable profits or dividends, procure the winding-up, liquidation or dissolution of Shanghai Guangcheng, amend its articles of association or provide any loans to, or borrow any loans from, third parties or provide security or guarantee, or undertake any substantive obligations beyond the ordinary course of business. The exclusive call option agreement will remain effective until all equity options in Shanghai Guangcheng held by such shareholders are transferred or assigned to Shanghai Xincheng or its designated representatives.

Loan Agreement

Shareholders of Shanghai Guangcheng have entered into a loan agreement, as amended from time to time, with Shanghai Xincheng on August 4, 2020. Pursuant to the loan agreement, Shanghai Xincheng provided such shareholders with a long-term interest-free loan. The proceeds from the loans were used for the investment in or general business development of Shanghai Guangcheng. The loans can be repaid by transferring the shareholders’ respective equity interests in Shanghai Guangcheng to Shanghai Xincheng or its designee.

Spousal Consent Letter

In addition to the contractual arrangements discussed above, each of the respective spouses of the individual shareholders of Nanjing Xingmu has executed an additional spousal consent letter which contains terms as described below. Pursuant to the spousal consent letters dated September 26, 2019, each of the respective spouses of the individual shareholders of Nanjing Xingmu, unconditionally and irrevocably agreed that the equity interest in Nanjing Xingmu held by and registered in the name of his/her spouse will be disposed of pursuant to the equity pledge agreement, the exclusive call option agreement and the shareholders’ voting rights proxy agreement. The spouse agreed not to assert any rights over the equity interest in Nanjing Xingmu held by his/her spouse. In addition, in the event that the spouse obtains any equity interest in Nanjing Xingmu held by his/her spouse for any reason, the spouse agreed to be bound by the contractual arrangements.

These contractual arrangements may not be as effective as direct ownership in providing us with control over the VIEs. If the VIEs or their respective shareholders fail to perform their respective obligations under the contractual arrangements, we could be limited in our ability to enforce the contractual arrangements that give us effective control over our business operations in the PRC and may have to incur substantial costs and expend additional resources to enforce such arrangements. We may also have to rely on legal remedies under PRC law, including seeking specific performance or injunctive relief, and claiming damages, which we cannot assure will be effective under PRC law. As of the date of this annual report, to the best knowledge of our Company, our directors and management, the VIE agreements have not been tested in a court of law in the PRC.

 

5


Table of Contents

In the opinion of Commerce & Finance Law Offices, our PRC counsel:

 

   

the ownership structures of the VIEs do not contravene any PRC laws or regulations currently in effect; and

 

   

the agreements under the contractual arrangements among Shanghai Xincheng, Shanghai Guangcheng and their respective shareholders, among Xingmu WFOE, Nanjing Xingmu and their respective shareholders, among Meiyizhi WFOE, Suzhou Xingyun and their respective shareholders, as well as among Shanghai Xincheng, Suzhou Taicheng and their respective shareholders governed by PRC laws are valid and binding upon each party to such agreements and enforceable against each party thereto in accordance with their terms and applicable PRC laws and regulations currently in effect.

There are substantial uncertainties regarding the interpretation and application of current and future PRC laws, regulations and rules. In particular, in March 2019, the National People’s Congress of the PRC adopted the PRC Foreign Investment Law, which became effective on January 1, 2020. Among other things, the PRC Foreign Investment Law defines the “foreign investment” as investment activities in China by foreign investors in a direct or indirect manner, including those circumstances explicitly listed thereunder as establishing new projects or foreign invested enterprises or acquiring shares of enterprises in China, and other approaches of investment as stipulated by laws, administrative regulations or otherwise regulated by the State Council. The PRC Foreign Investment Law leaves uncertainty as to whether foreign investors’ controlling PRC onshore variable interest entities via contractual arrangements will be recognized as “foreign investment” and thus be subject to the restrictions and/or prohibitions on foreign investments. Accordingly, the PRC regulatory authorities may in the future take a view that is contrary to the above opinion of our PRC counsel. If the PRC government finds that the VIE agreements that establish the structure for operating our podcasts, audio entertainment and other internet related businesses or for importing veterinary drugs do not comply with PRC government restrictions on foreign investment in certain industries, such as value-added telecommunications services business, or if these regulations change or are interpreted differently in the future, our ADSs may decline in value or become worthless, we could be subject to severe penalties, including being prohibited from continuing operations. For detailed discussion, see “Item 3. Key Information—3.D. Risk Factors—Risks Related to Our Corporate Structure and Contractual Arrangements.”

Cash Flows through Our Organization

Transfer of Funds and Other Assets

We currently do not have cash management policies that dictate how funds are transferred between us, our subsidiaries and the VIEs. In practice, we estimate and allocate funds to our WFOE and the VIEs based on their respective available cash balances and forecasted cash requirements. Under relevant PRC laws and regulations, we are permitted to remit funds to the VIEs through loans rather than capital contributions. The following diagram summarizes how funds were transferred among Boqii, our subsidiaries, and the VIEs as of March 31, 2023.

 

LOGO

 

6


Table of Contents

As of March 31, 2023, Boqii Holding Limited had made cumulative capital contributions of RMB1,151.1 million (US$167.6 million) to its PRC subsidiaries through intermediate holding companies, and were accounted as long-term investments of Boqii Holding Limited. Furthermore, funds equivalent to RMB9.8 million, RMB31.4 million and nil were provided to the PRC subsidiaries as loans for the fiscal years ended March 31, 2021, 2022 and 2023, respectively, which were accounted as intra-Group payables due to the Group’s entities. These funds have been used by the Company’s PRC subsidiaries for their operations.

The VIEs may transfer cash to the relevant WFOEs by paying service fees according to the exclusive business cooperation agreements. Pursuant to these agreements between each of the VIEs and its corresponding WFOEs, each of the VIEs agrees to pay the relevant WFOE for services related to design and maintenance of the e-commerce platform, consulting services, technical training, research, planning and development of the market and customer support at an amount based on 100% of the balance of the gross consolidated profits of each VIE after offsetting the accumulated losses for the preceding financial years and deducting the working capital, expenses, taxes and other statutory contributions required for any financial year, or the amount determined by the WFOE in accordance with the terms of the agreements. Considering the future operating and cash flow needs of the VIEs, for the years ended March 31, 2021, 2022 and 2023, no service fees were charged to the VIEs by the WFOEs, and no payments were made by the VIEs under these agreements. If there is any amount payable to relevant WFOEs under the VIE agreements, the VIEs will settle the amount accordingly. For more information, see “—Condensed Consolidating Schedule” and consolidated financial statements included elsewhere in this annual report. For any amounts owed by the VIEs to our PRC subsidiaries under the VIE agreements, unless otherwise required by PRC governmental authorities, we are able to settle such amounts without limitations under the current effective PRC laws and regulations, provided that the VIEs have sufficient funds to do so.

Dividend Distribution to U.S. Investors and Tax Consequences

We have not previously declared or paid any cash dividend, dividend in kind or distributions, and have no plan to declare or pay any dividends or distributions in the near future on our shares or the ADSs representing our ordinary shares. We currently intend to retain most, if not all, of our available funds and any future earnings to operate and expand our business. For more information, see “Item 8. Financial Information—8.A. Consolidated Statements and Other Financial Information—Dividend Policy.”

For purposes of illustration, the following discussion reflects the hypothetical taxes that might be required to be paid within Mainland China, assuming that: (i) we have taxable earnings, and (ii) we determine to pay a dividend in the future:

 

     Taxation Scenario(1)
Statutory Tax and
Standard Rates
 

Hypothetical pre-tax earnings(2)

     100.0

Tax on earnings at statutory rate of 25%(3)

     (25.0 )% 

Net earnings available for distribution

     75.0

Withholding tax at standard rate of 10%(4)

     (7.5 )% 

Net distribution to Boqii Holding Limited /shareholders

     67.5

Notes:

 

(1)

For purposes of this example, the tax calculation has been simplified. The hypothetical book pre-tax earnings amount, not considering timing differences, is assumed to equal taxable income in China.

(2)

Under the terms of VIE agreements, our PRC subsidiaries may charge the VIEs for services provided to VIEs. These fees shall be recognized as expenses of the VIEs, with a corresponding amount as service income by our PRC subsidiaries and eliminate in consolidation. For income tax purposes, our PRC subsidiaries and the VIEs file income tax returns on a separate company basis. The fees paid are recognized as a tax deduction by the VIEs and as income by our PRC subsidiaries and are tax neutral.

(3)

Certain of our subsidiaries and the VIEs qualifies for a 15% preferential income tax rate in China. However, such rate is subject to qualification, is temporary in nature, and may not be available in a future period when distributions are paid. For purposes of this hypothetical example, the table above reflects a maximum tax scenario under which the full statutory rate would be effective.

(4)

The PRC Enterprise Income Tax Law imposes a withholding income tax of 10% on dividends distributed by a foreign invested enterprise, or FIE, to its immediate holding company outside of China. A lower withholding income tax rate of 5% is applied if the FIE’s immediate holding company is registered in Hong Kong or other jurisdictions that have a tax treaty arrangement with China, subject to a qualification review at the time of the distribution. For purposes of this hypothetical example, the table above assumes a maximum tax scenario under which the full withholding tax would be applied.

 

7


Table of Contents

The table above has been prepared under the assumption that all profits of the VIEs will be distributed as fees to our PRC subsidiaries under tax neutral contractual arrangements. If, in the future, the accumulated earnings of the VIEs exceed the fees paid to our PRC subsidiaries (or if the current and contemplated fee structure between the intercompany entities is determined to be non-substantive and disallowed by Chinese tax authorities), the VIEs could, as a matter of last resort, make a nondeductible transfer to our PRC subsidiaries for the amounts of the stranded cash in the VIEs. This would result in such transfer being nondeductible expenses for the VIEs but still taxable income for the PRC subsidiaries. Such a transfer and the related tax burdens would reduce our after-tax income to approximately 50.6% of the pre-tax income. Our management believes that there is only a remote possibility that this scenario would happen.

For PRC and United States federal income tax consideration of an investment in the ADSs, see “Item 10. Additional Information—10.E. Taxation.”

Restrictions on Foreign Exchange and the Ability to Transfer Cash between Entities, Across Borders and to U.S. Investors

Boqii Holding Limited’s ability to pay dividends, if any, to its shareholders and ADS holders and to service any debt it may incur will depend upon dividends paid by our PRC subsidiaries. Under PRC laws and regulations, our PRC subsidiaries are subject to certain restrictions with respect to paying dividends or otherwise transferring any of their net assets offshore to Boqii Holding Limited. In particular, under the current effective PRC laws and regulations, dividends may be paid only out of distributable profits. Distributable profits are the net profit as determined under PRC GAAP, less any recovery of accumulated losses and appropriations to statutory and other reserves required to be made. Each of our PRC subsidiaries is required to set aside at least 10% of its after-tax profits each year, after making up previous years’ accumulated losses, if any, to fund certain statutory reserve funds, until the aggregate amount of such a fund reaches 50% of its registered capital. As a result, our PRC subsidiaries may not have sufficient distributable profits to pay dividends to us in the near future.

Furthermore, if certain procedural requirements are satisfied, the payment of current account items, including profit distributions and trade and service related foreign exchange transactions, can be made in foreign currencies without prior approval from State Administration of Foreign Exchange, or SAFE, or its local branches. However, where RMB is to be converted into foreign currency and remitted out of China to pay capital expenses, such as the repayment of loans denominated in foreign currencies, approval from or registration with competent government authorities or its authorized banks is required. The PRC government may take measures at its discretion from time to time to restrict access to foreign currencies for current account or capital account transactions. If the foreign exchange control system prevents us from obtaining sufficient foreign currencies to satisfy our foreign currency demands, we may not be able to pay dividends in foreign currencies to our offshore intermediary holding companies or ultimate parent company, and therefore, our shareholders or investors in our ADSs. Further, we cannot assure you that new regulations or policies will not be promulgated in the future, which may further restrict the remittance of RMB into or out of the PRC. We cannot assure you, in light of the restrictions in place, or any amendment to be made from time to time, that our current or future PRC subsidiaries will be able to satisfy their respective payment obligations that are denominated in foreign currencies, including the remittance of dividends outside of the PRC. If any of our subsidiaries incurs debt on its own behalf in the future, the instruments governing such debt may restrict its ability to pay dividends to Boqii Holding Limited. In addition, our PRC subsidiaries are required to make appropriations to certain statutory reserve funds, which are not distributable as cash dividends except in the event of a solvent liquidation of the companies.

 

8


Table of Contents

Condensed Consolidating Schedule

The following tables present the condensed consolidating schedules of financial information of Boqii Holding Limited, our subsidiaries that are the primary beneficiaries of VIEs and their subsidiaries, the VIEs and their subsidiaries, and other subsidiaries for the periods and as of the dates indicated.

 

    As of March 31, 2021  
   

Boqii Holding
Limited

   

All
others

   

Primary
Beneficiaries of
VIEs and their
subsidiaries

   

VIEs and their
subsidiaries

   

Eliminating
adjustments

   

Consolidated
totals

 
    (RMB in thousands)  

ASSETS

           

Current assets:

           

Cash and cash equivalents

    18,285       146,671       109,395       17,886       —         292,237  

short-term investments

    —         118,546       50,000       —         —         168,546  

Accounts receivable, net

    —         13,015       5,324       27,393       —         45,732  

Inventories, net

    —         14,411       65,791       11,349       —         91,551  

Prepayments and other current assets

    2,638       42,183       6,995       33,445       —         85,261  

Amounts due from related parties

    —         —         —         11,465       —         11,465  

Intra-Group receivables due from the Group’s entities(1)

    —         44,632       574,610       47,592       (666,834     —    

Non-current assets:

           

Property and equipment, net

    —         14       —         8,372       —         8,386  

Intangible assets

    —         —         28,628       909       —         29,537  

Operating lease right-of-use assets

    —         —         1,498       27,736       —         29,234  

Goodwill

    —         —         39,690       494       —         40,184  

Long-term investments

    —         —         —         74,330       —         74,330  

Other non-current asset

    344       317       1,017       2,433       —         4,111  

Long-term investments to the Group’s entities(2)

    66,868       —         —         —         (66,868     —    
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total assets

    88,135       379,789       882,948       263,404       (733,702     880,574  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

LIABILITIES, MEZZANINE EQUITY AND SHAREHOLDERS’ EQUITY

           

Current liabilities:

           

Short-term borrowings

    —         32,857       49,225       3,484       —         85,566  

Accounts payable

    —         264       41,644       29,940       —         71,848  

Salary and welfare payable

    —         738       720       4,851       —         6,309  

Accrued liabilities and other current liabilities

    4,055       677       787       24,536       —         30,055  

Amounts due to related parties, current

    —         —         —         910       —         910  

Contract liabilities

    —         —         160       3,706       —         3,866  

Operating lease liabilities, current

    —         —         2,005       6,058       —         8,063  

Derivative liabilities

    444       9,362       190       —         —         9,996  

Intra-Group payables due to the Group’s entities(1)

    962       19,188       35,572       611,112       (666,834     —    

Non-current liabilities:

           

Deferred tax liabilities

    —         —         7,106       1,852       —         8,958  

Operating lease liabilities, non-current

    —         —         —         19,997       —         19,997  

Long-term borrowings

    —         —         67,203       872       —         68,075  

Amounts due to related parties, non-current

    —         —         —         —         —         —    

Other debts, non-current

    —         —         18,170       415,122       —         433,292  

Investments deficit to the Group’s entities(2)

    —         243,889       865,920       —         (1,109,809     —    
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total liabilities

    5,461       306,975       1,088,702       1,122,440       (1,776,643     746,935  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Mezzanine equity:

           

Redeemable non-controlling interests

    —         5,946       —         —         —         5,946  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total mezzanine equity

    —         5,946       —         —         —         5,946  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Shareholders’ equity:

           

Total Boqii Holding Limited shareholders’ equity

    82,674       66,868       (243,889     (865,920     1,042,941       82,674  

Non-controlling interests

    —         —         38,135       6,884       —         45,019  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total shareholders’ equity

    82,674       66,868       (205,754     (859,036     1,042,941       127,693  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total liabilities, mezzanine equity and shareholders’ equity

    88,135       379,789       882,948       263,404       (733,702     880,574  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

9


Table of Contents
     As of March 31, 2022  
    

Boqii Holding
Limited

    

All
others

   

Primary
Beneficiaries of
VIEs and their
subsidiaries

   

VIEs and their
subsidiaries

   

Eliminating
adjustments

   

Consolidated
totals

 
     (RMB in thousands)  

ASSETS

             

Current assets:

             

Cash and cash equivalents

     1,166        112,876       28,246       20,567       —         162,855  

short-term investments

     —          128,084       —         —         —         128,084  

Accounts receivable, net

     —          2,704       15,092       31,435       —         49,231  

Inventories, net

     —          4,777       89,130       16,014       —         109,921  

Prepayments and other current assets

     9,727        13,154       36,750       57,107       —         116,738  

Amounts due from related parties

     —          —         —         11,726       —         11,726  

Intra-Group receivables due from the Group’s entities(1)

     —          80,224       896,341       16,535       (993,100     —    

Non-current assets:

             

Property and equipment, net

     —          61       1,003       6,715       —         7,779  

Intangible assets

     —          —         25,037       507       —         25,544  

Operating lease right-of-use assets

     —          —         2,879       35,688       —         38,567  

Goodwill

     —          —         39,690       994       —         40,684  

Long-term investments

     670        —         —         81,649       —         82,319  

Other non-current asset

     —          306       1,166       3,389       —         4,861  

Long-term investments to the Group’s entities(2)

     189,471        —         —         —         (189,471     —    
  

 

 

    

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total assets

     201,034        342,186       1,135,334       282,326       (1,182,571     778,309  
  

 

 

    

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

LIABILITIES, MEZZANINE EQUITY AND SHAREHOLDERS’ EQUITY

             

Current liabilities:

             

Short-term borrowings

     —          31,741       128,513       872       —         161,126  

Accounts payable

     —          39       39,041       55,144       —         94,224  

Salary and welfare payable

     —          827       447       5,597       —         6,871  

Accrued liabilities and other current liabilities

     349        1,189       1,369       24,417       —         27,324  

Amounts due to related parties, current

     —          —         215       4       —         219  

Contract liabilities

     —          —         —         7,007       —         7,007  

Operating lease liabilities, current

     —          —         2,763       7,238       —         10,001  

Derivative liabilities

     —          9,086       —         —         —         9,086  

Intra-Group payables due to the Group’s entities(1)

     1,510        12,123       33,507       945,960       (993,100     —    

Non-current liabilities:

             

Deferred tax liabilities

     —          —         4,847       —         —         4,847  

Operating lease liabilities, non-current

     —          —         —         28,197       —         28,197  

Other debts, non-current

     —          —         23,188       157,874       —         181,062  

Investments deficit to the Group’s entities(2)

     —          91,196       955,158       —         (1,046,354     —    
  

 

 

    

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total liabilities

     1,859        146,201       1,189,048       1,232,310       (2,039,454     529,964  
  

 

 

    

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Mezzanine equity:

             

Redeemable non-controlling interests

     —          6,522       —         —         —         6,522  
  

 

 

    

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total mezzanine equity

     —          6,522       —         —         —         6,522  
  

 

 

    

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Shareholders’ equity:

             

Total Boqii Holding Limited shareholders’ equity

     199,175        189,471       (91,196     (955,158     856,883       199,175  

Non-controlling interests

     —          (8     37,482       5,174       —         42,648  
  

 

 

    

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total shareholders’ equity

     199,175        189,463       (53,714     (949,984     856,883       241,823  
  

 

 

    

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total liabilities, mezzanine equity and shareholders’ equity

     201,034        342,186       1,135,334       282,326       (1,182,571     778,309  
  

 

 

    

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

10


Table of Contents
    As of March 31, 2023  
   

Boqii Holding
Limited

   

All
others

   

Primary
beneficiaries of
VIEs and their
subsidiaries

   

VIEs and
their
subsidiaries

   

Eliminating
adjustments

   

Consolidated
totals

 
    (RMB in thousands)  

ASSETS

           

Current assets:

           

Cash and cash equivalents

    129       6,420       67,779       15,522       —         89,850  

Short-term investments

    —         69,797       —         —         —         69,797  

Accounts receivable, net

    —         1,763       41,807       33,172       —         76,742  

Inventories, net

    —         1,693       51,465       27,894       —         81,052  

Prepayments and other current assets

    10,507       8,268       12,293       48,291       —         79,359  

Amounts due from related parties

    100       5,497       —         3,782       —         9,379  

Intra-Group receivables due from the Group’s entities(1)

    —         96,497       1,035,667       83,700       (1,215,864     —    

Non-current assets:

           

Property and equipment, net

    —         29       802       4,661       —         5,492  

Intangible assets

    —         50       21,443       101       —         21,594  

Operating lease right-of-use assets

    —         —         49       22,305       —         22,354  

Goodwill

    —         —         —         —         —         —    

Long-term investments

    102       —         —         75,505       —         75,607  

Long-term investments to the Group’s entities

    170,476       —         —         —         (170,476     —    

Amounts due from related parties, non-current

    —         —         —         2,988       —         2,988  

Other non-current asset

    —         262       1,105       5,219       —         6,586  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total assets

    181,314       190,276       1,232,410       323,140       (1,386,340     540,800  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

LIABILITIES, MEZZANINE EQUITY AND SHAREHOLDERS’ EQUITY

           

Current liabilities:

           

Short-term borrowings

    —         —         85,898       363       —         86,261  

Accounts payable

    —         92       42,471       13,459       —         56,022

Salary and welfare payable

    —         371       946       5,573       —         6,890  

Accrued liabilities and other current liabilities

    350       1,697       3,161       16,896       —         22,104  

Amounts due to related parties, current

    —         —         450       21       —         471  

Intra-Group payables due to the Group’s entities(1)

    2,681       12,112       105,619       1,095,452       (1,215,864     —    

Contract liabilities

    —         —         —         4,471       —         4,471  

Operating lease liabilities, current

    —         —         13       9,207       —         9,220  

Derivative liabilities

    —         7,850       2,851       —         —         10,701  

Non-current liabilities:

           

Deferred tax liabilities

    —         —         5,325       (1,184     —         4,141  

Operating lease liabilities, non-current

    —         —         —         12,741       —         12,741  

Long-term debt

    —         —         27,346       75,481       —         102,827  

Investments deficit to the Group’s entities(2)

    —         (9,510     915,738       —         (906,228     —    
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total liabilities

    3,031       12,612       1,189,818       1,232,480       (2,122,092     315,849  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Mezzanine equity:

           

Redeemable non-controlling interests

    —         7,197       —         —         —         7,197  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total mezzanine equity

    —         7,197       —         —         —         7,197  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Shareholders’ equity:

           

Total Boqii Holding Limited shareholders’ deficit

    178,283       170,476       9,510       (915,738     735,752       178,283  

Non-controlling interests

    —         (9     33,082       6,398       —         39,471  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total shareholders’ equity

    178,283       170,467       42,592       (909,340     735,752       217,754  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total liabilities, mezzanine equity and shareholders’ equity

    181,314       190,276       1,232,410       323,140       (1,386,340     540,800  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Notes:

 

(1)

Represents the elimination of intercompany balances among Boqii Holding Limited, the Primary Beneficiaries of VIEs and their subsidiaries, the Other Subsidiaries, and the VIEs and their subsidiaries that we consolidate.

(2)

Represents the elimination of investments among Boqii Holding Limited, the Primary Beneficiaries of VIEs and their subsidiaries, the Other Subsidiaries, and the VIEs and their subsidiaries that we consolidate.

 

11


Table of Contents
     Year Ended March 31, 2021  
    

Boqii Holding
Limited

   

All
others

   

Primary
Beneficiaries of
VIEs and their
subsidiaries

   

VIEs and their
subsidiaries

   

Eliminating
adjustments

   

Consolidated
totals

 
     (RMB in thousands)  

Net revenues:

            

Third-party revenues

     —         121,190       154,277       735,518       —         1,010,985  

Intra-Group revenues(1)

     —         —         406,049       48,374       (454,423     —    
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total revenues

     —         121,190       560,326       783,892       (454,423     1,010,985  
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Cost of revenues:

            

Third-party cost of revenues

     —         (94,519     (356,692     (372,475     —         (823,686

Intra-Group cost of revenues(1)

     —         —         (132,173     (297,844     430,017       —    
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total cost of revenues

     —         (94,519     (488,865     (670,319     430,017       (823,686
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Gross profit

     —         26,671       71,461       113,573       (24,406     187,299  
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Operating expenses:

            

Third-party operating expenses

     (19,320     (34,391     (85,699     (254,951     —         (394,361

Intra-Group operating expenses(1)

     —         —         (17,149     (7,257     24,406       —    
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total operating expenses

     (19,320     (34,391     (102,848     (262,208     24,406       (394,361
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Other income, net

     —         —         56       1,011       —         1,067  

Loss from operations

     (19,320     (7,720     (31,331     (147,624     —         (205,995
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Equity in loss of the Group’s entities(2)

     (199,065     (196,170     (166,484     —         561,719       —    

Non-operating income/(expense)

     23,941       4,825       2,000       (18,162     —         12,604  
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Loss before income tax expenses

     (194,444     (199,065     (195,815     (165,786     561,719       (193,391
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Income tax benefits

     —         —         891       (20     —         871  

Share of results of equity investees

     —         —         —         (696     —         (696
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net loss

     (194,444     (199,065     (194,924     (166,502     561,719       (193,216
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Less: Net income attributable to the non-controlling interest shareholders

     —         —         1,246       (18     —         1,228  
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net loss attributable to Boqii Holding Limited

     (194,444     (199,065     (196,170     (166,484     561,719       (194,444
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

12


Table of Contents
     Year Ended March 31, 2022  
    

Boqii Holding
Limited

   

All
others

   

Primary
Beneficiaries of
VIEs and their
subsidiaries

   

VIEs and their
subsidiaries

   

Eliminating
adjustments

   

Consolidated
totals

 
     (RMB in thousands)  

Net revenues:

            

Third-party revenues

     —         42,769       266,280       877,380       —         1,186,429  

Intra-Group revenues(1)

     —         —         550,585       56,079       (606,664     —    
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total revenues

     —         42,769       816,865       933,459       (606,664     1,186,429  
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Cost of revenues:

            

Third-party cost of revenues

     —         (38,203     (744,834     (160,661     —         (943,698

Intra-Group cost of revenues(1)

     —         (637     (1,761     (550,585     552,983       —    
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total cost of revenues

     —         (38,840     (746,595     (711,246     552,983       (943,698
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Gross profit

     —         3,929       70,270       222,213       (53,681     242,731  
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Operating expenses:

            

Third-party operating expenses

     (17,058     (21,896     (54,015     (288,291     —         (381,260

Intra-Group operating expenses(1)

     —         —         (53,681     —         53,681       —    
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total operating expenses

     (17,058     (21,896     (107,696     (288,291     53,681       (381,260
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Other income, net

     —         —         182       98       —         280  

Loss from operations

     (17,058     (17,967     (37,244     (65,980     —         (138,249
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Equity in loss of the Group’s entities(2)

     (132,683     (115,665     (81,790     —         330,138       —    

Non-operating income/(expense)

     21,351       941       1,825       (20,680     —         3,437  
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Loss before income tax expenses

     (128,390     (132,691     (117,209     (86,660     330,138       (134,812
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Income tax benefits

     —         —         890       681       —         1,571  

Share of results of equity investees

     —         —         —         418       —         418  
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net loss

     (128,390     (132,691     (116,319     (85,561     330,138       (132,823
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Less: Net income attributable to the non-controlling interest shareholders

     —         (8     (654     (3,771     —         (4,433
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net loss attributable to Boqii Holding Limited

     (128,390     (132,683     (115,665     (81,790     330,138       (128,390
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

13


Table of Contents
     Year Ended March 31, 2023  
    

Boqii Holding
Limited

   

All
others

   

Primary
Beneficiaries of
VIEs and their
subsidiaries

   

VIEs and their
subsidiaries

   

Eliminating
adjustments

   

Consolidated
totals

 
     (RMB in thousands)  

Net revenues:

            

Third-party revenues

     —         8,937       297,005       786,152       —         1,092,094  

Intra-Group revenues(1)

     —         —         534,559       86,463       (621,022     —    
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total revenues

     —         8,937       831,564       872,615       (621,022     1,092,094  
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Cost of revenues:

            

Third-party cost of revenues

     —         (8,967     (767,831     (81,810     —         (858,608

Intra-Group cost of revenues(1)

     —         —         (982     (534,518     535,500       —    
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total cost of revenues

     —         (8,967     (768,813     (616,328     535,500       (858,608
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Gross profit

     —         30       (62,751     (256,287     85,522       (233,486
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Operating expenses:

            

Third-party operating expenses

     1,076       (10,342     (49,737     (237,852     —         (296,855

Impairment of goodwill

     —         —         (39,690     (994     —         (40,684

Intra-Group operating expenses(1)

     —         —         (85,481     (41     85,522       —    
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total operating expenses

     1,076       (10,372     (174,908     (238,887     85,522       (337,539
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Other income/(expense), net

     —         —         127       158       —         285  
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Loss from operations

     1,076       (10,372     (112,030     17,558       —         (103,768
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Equity in loss of the Group’s entities(2)

     (109,424     (101,087     16,245       —         194,266       —    

Non-operating income/(expense)

     5,550       2,033       (10,591     (29     —         (3,037
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Loss before income tax expenses

     (102,798     (109,426     (106,376     17,529       194,266       (106,805
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Income tax benefits

     —         —         890       21       —         911  

Share of results of equity investees

     —         —         —         (82     —         (82
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net loss

     (102,798     (109,426     (105,486     17,468       194,266       (105,976
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Less: Net income attributable to the non-controlling interest shareholders

     —         (1     (4,400     1,224       —         (3,177
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net loss attributable to Boqii Holding Limited

     (102,798     (109,425     (101,086     16,244       194,266       (102,799
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Notes:

 

(1)

Represents the elimination of the intercompany transactions at the consolidation level. For the fiscal years ended March 31, 2021, 2022 and 2023, the primary beneficiary of the VIE didn’t charge any service fees according to the exclusive consultation and service agreements.

(2)

Represents the elimination of investments among Boqii Holding Limited, the primary beneficiaries of VIEs and their subsidiaries, the Other Subsidiaries and the VIEs and their subsidiaries that we consolidate.

 

14


Table of Contents
    Year Ended March 31, 2021  
   

Boqii Holding
Limited

   

All
others

   

Primary
Beneficiaries of
VIEs and their
subsidiaries

   

VIEs and their
subsidiaries

   

Eliminating
adjustments

   

Consolidated
totals

 
    (RMB in thousands)  

Cash flows from operating activities:

           

Net cash provided by/(used in) transactions with external parties

    2,193       (161,806     (507,640     419,767       —         (247,486

Net cash provided by/(used in) transactions with the Group’s entities

    34       (6,552     337,582       (331,064     —         —    
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net cash provided by/(used in) operating activities

    2,227       (168,358     (170,058     88,703       —         (247,486
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Cash flows from investing activities:

           

Capital contribution to the Group’s entities

    (620,373     (148,624     —         —         768,997       —    

Cash flows of loan funding provided to the Group’s entities, net of repayments received

    —         38,859       (80,577     (5,242     46,960       —    

Other investing activities

    (18,613     (45,942     (87,890     (31,972     —         (184,417
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net cash used in investing activities

    (638,986     (155,707     (168,467     (37,214     815,957       (184,417
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Cash flows from financing activities:

           

Proceeds from the initial public offering, net of underwriter discounts and commissions and other offering costs paid

    393,698       —         —         —         —         393,698  

Capital contribution from the Group’s entities

    —         452,553       316,444       —         (768,997     —    

Cash flows of loan funding received from the Group’s entities, net of repayments made

    —         —         5,243       41,717       (46,960     —    

Other financing activities

    266,668       19,845       80,431       (112,151     —         254,793  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net cash provided by/(used in) financing activities

    660,366       472,398       402,118       (70,434     (815,957     648,491  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

15


Table of Contents
    Year Ended March 31, 2022  
   

Boqii Holding
Limited

   

All
others

   

Primary
Beneficiaries of
VIEs and their
subsidiaries

   

VIEs and their
subsidiaries

   

Eliminating
adjustments

   

Consolidated
totals

 
    (RMB in thousands)  

Cash flows from operating activities:

           

Net cash provided by/(used in) transactions with external parties

    (3,626     16,466       (686,545     526,201       —         (147,504

Net cash provided by/(used in) transactions with the Group’s entities

    563       (29     328,791       (329,325     —         —    
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net cash provided by/(used in) operating activities

    (3,063     16,437       (357,754     196,876       —         (147,504
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Cash flows from investing activities:

           

Capital contribution to the Group’s entities

    (242,713     (252,255     —         —         494,968       —    

Cash flows of loan funding provided to the Group’s entities, net of repayments received

    —         (22,616     (91,552     6,294       107,874       —    

Other investing activities

    (34,687     (9,593     83,909       (18,482     —         21,147  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net cash provided by/(used in) investing activities

    (277,400     (284,464     (7,643     (12,188     602,842       21,147  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Cash flows from financing activities:

           

Capital contribution from the Group’s entities

    —         242,713       252,255       —         (494,968     —    

Cash flows of loan funding received from the Group’s entities, net of repayments made

    —         (7,167     23,247       91,794       (107,874     —    

Other financing activities

    264,010       —         11,891       (273,906     —         1,995  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net cash provided by/(used in) financing activities

    264,010       235,546       287,393       (182,112     (602,842     1,995  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

16


Table of Contents
    Year Ended March 31, 2023  
   

Boqii Holding
Limited

   

All
others

   

Primary
Beneficiaries of
VIEs and their
subsidiaries

   

VIEs and their
subsidiaries